speb/financial-data huggingface dataset:
HCAT cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -508000.00
HCAT cash_flow (annual, 2024-12-31) — Purchase Of Investment: -168307000.00
HCAT cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1616000.00
HCAT balance_sheet (annual, 2024-12-31) — Receivables: 57182000.00
HCAT income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 165805000.00
HCAT income_statement (annual, 2024-12-31) — Reconciled Depreciation: 41431000.00
HCAT cash_flow (annual, 2024-12-31) — Repayment Of Debt: -959000.00
HCAT cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
HCAT income_statement (annual, 2024-12-31) — Research And Development: 57950000.00
HCAT income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 9993000.00
HCAT balance_sheet (annual, 2024-12-31) — Retained Earnings: -1186672000.00
HCAT cash_flow (annual, 2024-12-31) — Sale Of Investment: 242067000.00
HCAT cash_flow (annual, 2024-12-31) — Sale Of PPE: 13000.00
HCAT income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 53147000.00
HCAT income_statement (annual, 2024-12-31) — Selling General And Administration: 99011000.00
HCAT balance_sheet (annual, 2024-12-31) — Share Issued: 64043799.00
HCAT income_statement (annual, 2024-12-31) — Special Income Charges: -12193000.00
HCAT cash_flow (annual, 2024-12-31) — Stock Based Compensation: 40128000.00
HCAT balance_sheet (annual, 2024-12-31) — Stockholders Equity: 365207000.00
HCAT balance_sheet (annual, 2024-12-31) — Tangible Book Value: 19396000.00
HCAT income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -2560530.00
HCAT income_statement (annual, 2024-12-31) — Tax Provision: 333000.00
HCAT income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
HCAT balance_sheet (annual, 2024-12-31) — Total Assets: 858929000.00
HCAT balance_sheet (annual, 2024-12-31) — Total Capitalization: 516385000.00
HCAT balance_sheet (annual, 2024-12-31) — Total Debt: 402265000.00
HCAT balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 365207000.00
HCAT income_statement (annual, 2024-12-31) — Total Expenses: 364197000.00
HCAT balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 493722000.00
HCAT balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 393279000.00
HCAT balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 167872000.00
HCAT income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -69806000.00
HCAT income_statement (annual, 2024-12-31) — Total Unusual Items: -12193000.00
HCAT income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -12193000.00
HCAT balance_sheet (annual, 2024-12-31) — Working Capital: 139800000.00
HCAT income_statement (quarterly, 2025-03-31) — +Operating Expense: 53250000.00
HCAT income_statement (quarterly, 2025-03-31) — +Total Revenue: 79413000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 8946000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 64046000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -42883000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -3000000.00
HCAT cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -914000.00
HCAT cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
HCAT income_statement (quarterly, 2025-03-31) — Basic Average Shares: 68552000.00
HCAT income_statement (quarterly, 2025-03-31) — Basic EPS: -0.35
HCAT cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 249645000.00
HCAT cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -5331000.00
HCAT cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -4661000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 19511000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1587085000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 341968000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 341968000.00
HCAT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -4712000.00
HCAT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 96762000.00
HCAT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 280000.00
HCAT cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -7196000.00
HCAT cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -944000.00
HCAT cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 15988000.00
HCAT cash_flow (quarterly, 2025-03-31) — Change In Payable: -7196000.00
HCAT cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -7196000.00
HCAT cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 764000.00
HCAT cash_flow (quarterly, 2025-03-31) — Change In Receivables: -6067000.00
HCAT cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 2545000.00
HCAT cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -6067000.00
HCAT cash_flow (quarterly, 2025-03-31) — Changes In Cash: 92330000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Common Stock: 1587085000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 376811000.00
HCAT cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -5000000.00
HCAT income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 43178000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 15158000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Current Assets: 422716000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 3760000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Current Debt: 231563000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 235323000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 71497000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 71497000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 339561000.00
HCAT cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 67000.00
HCAT cash_flow (quarterly, 2025-03-31) — Deferred Tax: 67000.00
HCAT cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 12320000.00
HCAT income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 12320000.00
HCAT cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 12320000.00
HCAT income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 12320000.00
HCAT income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 68552000.00
HCAT income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.35
HCAT income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -23742000.00
HCAT income_statement (quarterly, 2025-03-31) — EBIT: -16211000.00
HCAT income_statement (quarterly, 2025-03-31) — EBITDA: -3891000.00
HCAT cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -7000.00
HCAT cash_flow (quarterly, 2025-03-31) — End Cash Position: 341968000.00
HCAT cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -4712000.00
HCAT cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -5051000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 140000.00
HCAT income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 11856000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Goodwill: 313380000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 419780000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 67046000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Gross PPE: 86408000.00
HCAT income_statement (quarterly, 2025-03-31) — Gross Profit: 36235000.00
HCAT income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 0.00
HCAT income_statement (quarterly, 2025-03-31) — Interest Expense: 7316000.00
HCAT income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 7316000.00
HCAT income_statement (quarterly, 2025-03-31) — Interest Income: 3831000.00
HCAT income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 3831000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Interest Payable: 6053000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Invested Capital: 759665000.00
HCAT cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 96762000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Leases: 8473000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 15751000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 151291000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 167042000.00
HCAT cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -407000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 66058000.00
HCAT cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -41122000.00
HCAT cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -5000000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Net Debt: 40886000.00
HCAT income_statement (quarterly, 2025-03-31) — Net Income: -23742000.00
HCAT income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -23742000.00
HCAT income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -23742000.00
HCAT income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -23742000.00
HCAT income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -23742000.00
HCAT cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -23742000.00
HCAT income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -23742000.00
HCAT cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: 0.00
HCAT income_statement (quarterly, 2025-03-31) — Net Interest Income: -3485000.00
HCAT cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 143208000.00
HCAT cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -407000.00
HCAT cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -407000.00
HCAT income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -3485000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Net PPE: 43525000.00
HCAT cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -663000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -42969000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 407000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 407000.00
HCAT income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -735000.00
HCAT income_statement (quarterly, 2025-03-31) — Normalized Income: -21248760.00
HCAT cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 280000.00
HCAT income_statement (quarterly, 2025-03-31) — Operating Income: -17015000.00
HCAT income_statement (quarterly, 2025-03-31) — Operating Revenue: 79413000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 69587834.00
HCAT balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 16702000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 231563000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 140000.00
HCAT income_statement (quarterly, 2025-03-31) — Other Gand A: 11856000.00
HCAT income_statement (quarterly, 2025-03-31) — Other Income Expense: -3027000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 106400000.00
HCAT cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1651000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 5521000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 7721000.00
HCAT income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 129000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Other Properties: 11877000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 0.00
HCAT balance_sheet (quarterly, 2025-03-31) — Payables: 8946000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 24104000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 8637000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
HCAT income_statement (quarterly, 2025-03-31) — Pretax Income: -23527000.00
HCAT cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 695000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
HCAT cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 810000.00
HCAT cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -41122000.00
HCAT cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: 0.00
HCAT cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
HCAT cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -670000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Receivables: 64046000.00
HCAT income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 43178000.00
HCAT income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 12320000.00
HCAT cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -407000.00
HCAT cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -5000000.00
HCAT income_statement (quarterly, 2025-03-31) — Research And Development: 15186000.00
HCAT income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 3156000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1210414000.00
HCAT cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 143208000.00
HCAT cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 7000.00
HCAT income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 13888000.00
HCAT income_statement (quarterly, 2025-03-31) — Selling General And Administration: 25744000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Share Issued: 69587834.00
HCAT income_statement (quarterly, 2025-03-31) — Special Income Charges: -3156000.00
HCAT cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 7543000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 376811000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -42969000.00
HCAT income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -662760.00
HCAT income_statement (quarterly, 2025-03-31) — Tax Provision: 215000.00
HCAT income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
HCAT balance_sheet (quarterly, 2025-03-31) — Total Assets: 891542000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 528102000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Total Debt: 402365000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 376811000.00
HCAT income_statement (quarterly, 2025-03-31) — Total Expenses: 96428000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 514731000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 468826000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 175170000.00
HCAT income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -20171000.00
HCAT income_statement (quarterly, 2025-03-31) — Total Unusual Items: -3156000.00
HCAT income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -3156000.00
HCAT balance_sheet (quarterly, 2025-03-31) — Working Capital: 83155000.00
HCAT income_statement (quarterly, 2025-06-30) — +Operating Expense: 46566000.00
HCAT income_statement (quarterly, 2025-06-30) — +Total Revenue: 80721000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 8940000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 68378000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -46203000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -3300000.00
HCAT cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -19000.00
HCAT cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 28769000.00
HCAT income_statement (quarterly, 2025-06-30) — Basic Average Shares: 69626000.00
HCAT income_statement (quarterly, 2025-06-30) — Basic EPS: -0.59
HCAT cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 341968000.00
HCAT cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -5491000.00
HCAT cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -5425000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 19761000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1596707000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 50712000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 97338000.00
HCAT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -230099000.00
HCAT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -52225000.00
HCAT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -8997000.00
HCAT cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -5442000.00
HCAT cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -953000.00
HCAT cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -4565000.00
HCAT cash_flow (quarterly, 2025-06-30) — Change In Payable: -5442000.00
HCAT cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -5442000.00
HCAT cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 1704000.00
HCAT cash_flow (quarterly, 2025-06-30) — Change In Receivables: -4566000.00
HCAT cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -13822000.00
HCAT cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -4566000.00
HCAT cash_flow (quarterly, 2025-06-30) — Changes In Cash: -291321000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Common Stock: 1596707000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 347547000.00
HCAT cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
HCAT income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 42480000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 11451000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Current Assets: 180576000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 3878000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Current Debt: 1627000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 5505000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 67011000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 67011000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 98823000.00
HCAT cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -224000.00
HCAT cash_flow (quarterly, 2025-06-30) — Deferred Tax: -224000.00
HCAT cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 12684000.00
HCAT income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 12684000.00
HCAT cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 12684000.00
HCAT income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 12684000.00
HCAT income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 69626000.00
HCAT income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.59
HCAT income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -40978000.00
HCAT income_statement (quarterly, 2025-06-30) — EBIT: -35110000.00
HCAT income_statement (quarterly, 2025-06-30) — EBITDA: -22426000.00
HCAT cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 65000.00
HCAT cash_flow (quarterly, 2025-06-30) — End Cash Position: 50712000.00
HCAT cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -230099000.00
HCAT cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -14488000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 2232000.00
HCAT income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 8284000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Goodwill: 286095000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 384441000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 71678000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Gross PPE: 91947000.00
HCAT income_statement (quarterly, 2025-06-30) — Gross Profit: 38241000.00
HCAT income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 28769000.00
HCAT income_statement (quarterly, 2025-06-30) — Interest Expense: 5787000.00
HCAT income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 5787000.00
HCAT income_statement (quarterly, 2025-06-30) — Interest Income: 1659000.00
HCAT income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 1659000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Interest Payable: 3474000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Invested Capital: 500575000.00
HCAT cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -52225000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Leases: 8473000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 15883000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 151401000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 167284000.00
HCAT cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -230407000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 71129000.00
HCAT cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 8000.00
HCAT cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
HCAT balance_sheet (quarterly, 2025-06-30) — Net Debt: 102316000.00
HCAT income_statement (quarterly, 2025-06-30) — Net Income: -40978000.00
HCAT income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -40978000.00
HCAT income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -40978000.00
HCAT income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -40978000.00
HCAT income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -40978000.00
HCAT cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -40978000.00
HCAT income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -40978000.00
HCAT cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -296000.00
HCAT income_statement (quarterly, 2025-06-30) — Net Interest Income: -4128000.00
HCAT cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -46760000.00
HCAT cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -230407000.00
HCAT cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -230407000.00
HCAT income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -4128000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Net PPE: 45744000.00
HCAT cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 248000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -36894000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 329000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 329000.00
HCAT income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 6343000.00
HCAT income_statement (quarterly, 2025-06-30) — Normalized Income: -18250490.00
HCAT cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -8997000.00
HCAT income_statement (quarterly, 2025-06-30) — Operating Income: -8325000.00
HCAT income_statement (quarterly, 2025-06-30) — Operating Revenue: 80721000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 70267429.00
HCAT balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 14860000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 1627000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 2232000.00
HCAT income_statement (quarterly, 2025-06-30) — Other Gand A: 8284000.00
HCAT income_statement (quarterly, 2025-06-30) — Other Income Expense: -28444000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 98346000.00
HCAT cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -4030000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 5419000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 2197000.00
HCAT income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 325000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Other Properties: 12345000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 46626000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Payables: 8940000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 20391000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 5916000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
HCAT income_statement (quarterly, 2025-06-30) — Pretax Income: -40897000.00
HCAT cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 308000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
HCAT cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 300000.00
HCAT cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 8000.00
HCAT cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -296000.00
HCAT cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -46760000.00
HCAT cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: 230000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Receivables: 68378000.00
HCAT income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 42480000.00
HCAT income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 12684000.00
HCAT cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -230407000.00
HCAT cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
HCAT income_statement (quarterly, 2025-06-30) — Research And Development: 12392000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1251392000.00
HCAT cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
HCAT cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 18000.00
HCAT income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 13206000.00
HCAT income_statement (quarterly, 2025-06-30) — Selling General And Administration: 21490000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Share Issued: 70267429.00
HCAT income_statement (quarterly, 2025-06-30) — Special Income Charges: -28769000.00
HCAT cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 8323000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 347547000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -36894000.00
HCAT income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -6041490.00
HCAT income_statement (quarterly, 2025-06-30) — Tax Provision: 81000.00
HCAT income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
HCAT balance_sheet (quarterly, 2025-06-30) — Total Assets: 616180000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 498948000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Total Debt: 172789000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 347547000.00
HCAT income_statement (quarterly, 2025-06-30) — Total Expenses: 89046000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 268633000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 435604000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 169810000.00
HCAT income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -37094000.00
HCAT income_statement (quarterly, 2025-06-30) — Total Unusual Items: -28769000.00
HCAT income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -28769000.00
HCAT balance_sheet (quarterly, 2025-06-30) — Working Capital: 81753000.00
HCAT income_statement (quarterly, 2025-09-30) — +Operating Expense: 55325000.00
HCAT income_statement (quarterly, 2025-09-30) — +Total Revenue: 76323000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 4943000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 60109000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -49484000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -3600000.00
HCAT cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -345000.00
HCAT cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 6900000.00
HCAT income_statement (quarterly, 2025-09-30) — Basic Average Shares: 70377000.00
HCAT income_statement (quarterly, 2025-09-30) — Basic EPS: -0.32
HCAT cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 50712000.00
HCAT cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -5135000.00
HCAT cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -4552000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 18980000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1604039000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 40305000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 91540000.00
HCAT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -537000.00
HCAT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -9353000.00
HCAT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -464000.00
HCAT cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -3091000.00
HCAT cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -1009000.00
HCAT cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -8119000.00
HCAT cash_flow (quarterly, 2025-09-30) — Change In Payable: -3091000.00
HCAT cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -3091000.00
HCAT cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -534000.00
HCAT cash_flow (quarterly, 2025-09-30) — Change In Receivables: 7924000.00
HCAT cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -4829000.00
HCAT cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 7924000.00
HCAT cash_flow (quarterly, 2025-09-30) — Changes In Cash: -10354000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Common Stock: 1604039000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 331923000.00
HCAT cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
HCAT income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 38507000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 13114000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Current Assets: 165353000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 3855000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Current Debt: 1627000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 5482000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 58824000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 58824000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 87893000.00
HCAT cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 43000.00
HCAT cash_flow (quarterly, 2025-09-30) — Deferred Tax: 43000.00
HCAT cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 12614000.00
HCAT income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 12614000.00
HCAT cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 12614000.00
HCAT income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 12614000.00
HCAT income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 70377000.00
HCAT income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.32
HCAT income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -22229000.00
HCAT income_statement (quarterly, 2025-09-30) — EBIT: -16553000.00
HCAT income_statement (quarterly, 2025-09-30) — EBITDA: -3939000.00
HCAT cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -53000.00
HCAT cash_flow (quarterly, 2025-09-30) — End Cash Position: 40305000.00
HCAT cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -537000.00
HCAT cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -5599000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 1505000.00
HCAT income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 16069000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Goodwill: 285586000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 375140000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 63709000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Gross PPE: 89349000.00
HCAT income_statement (quarterly, 2025-09-30) — Gross Profit: 37816000.00
HCAT income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
HCAT income_statement (quarterly, 2025-09-30) — Interest Expense: 5635000.00
HCAT income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 5635000.00
HCAT income_statement (quarterly, 2025-09-30) — Interest Income: 1136000.00
HCAT income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 1136000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Interest Payable: 3531000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Invested Capital: 485062000.00
HCAT cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -9353000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Leases: 6200000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 15125000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 151512000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 166637000.00
HCAT cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -1071000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 75893000.00
HCAT cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
HCAT cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
HCAT balance_sheet (quarterly, 2025-09-30) — Net Debt: 112834000.00
HCAT income_statement (quarterly, 2025-09-30) — Net Income: -22229000.00
HCAT income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -22229000.00
HCAT income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -22229000.00
HCAT income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -22229000.00
HCAT income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -22229000.00
HCAT cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -22229000.00
HCAT income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -22229000.00
HCAT cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -328000.00
HCAT income_statement (quarterly, 2025-09-30) — Net Interest Income: -4499000.00
HCAT cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -4224000.00
HCAT cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -1071000.00
HCAT cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -1071000.00
HCAT income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -4499000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Net PPE: 39865000.00
HCAT cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -249000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -43217000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 385000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 385000.00
HCAT income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -3939000.00
HCAT income_statement (quarterly, 2025-09-30) — Normalized Income: -22229000.00
HCAT cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -464000.00
HCAT income_statement (quarterly, 2025-09-30) — Operating Income: -17509000.00
HCAT income_statement (quarterly, 2025-09-30) — Operating Revenue: 76323000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 70622681.00
HCAT balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 13704000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 1627000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 1505000.00
HCAT income_statement (quarterly, 2025-09-30) — Other Gand A: 16069000.00
HCAT income_statement (quarterly, 2025-09-30) — Other Income Expense: -180000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 89554000.00
HCAT cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 43000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 6770000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 290000.00
HCAT income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -180000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Other Properties: 7256000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 51235000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Payables: 4943000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 18057000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 5530000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
HCAT income_statement (quarterly, 2025-09-30) — Pretax Income: -22188000.00
HCAT cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 534000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
HCAT cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 300000.00
HCAT cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
HCAT cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -328000.00
HCAT cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -10464000.00
HCAT cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -255000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Receivables: 60109000.00
HCAT income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 38507000.00
HCAT income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 12614000.00
HCAT cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -1071000.00
HCAT cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
HCAT income_statement (quarterly, 2025-09-30) — Research And Development: 12281000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1273621000.00
HCAT cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 6240000.00
HCAT cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 6000.00
HCAT income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 14361000.00
HCAT income_statement (quarterly, 2025-09-30) — Selling General And Administration: 30430000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Share Issued: 70622681.00
HCAT income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
HCAT cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 7039000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 331923000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -43217000.00
HCAT income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
HCAT income_statement (quarterly, 2025-09-30) — Tax Provision: 41000.00
HCAT income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
HCAT balance_sheet (quarterly, 2025-09-30) — Total Assets: 587128000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 483435000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Total Debt: 172119000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 331923000.00
HCAT income_statement (quarterly, 2025-09-30) — Total Expenses: 93832000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 255205000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 421775000.00
HCAT balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 167312000.00
HCAT income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -17509000.00
HCAT income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
HCAT income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
HCAT balance_sheet (quarterly, 2025-09-30) — Working Capital: 77460000.00
HCAT income_statement (annual, 2025-12-31) — +Operating Expense: 194419000.00
HCAT income_statement (quarterly, 2025-12-31) — +Operating Expense: 36122000.00
HCAT income_statement (annual, 2025-12-31) — +Total Revenue: 311136000.00
HCAT income_statement (quarterly, 2025-12-31) — +Total Revenue: 74679000.00
HCAT balance_sheet (annual, 2025-12-31) — Accounts Payable: 9363000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 9363000.00
HCAT balance_sheet (annual, 2025-12-31) — Accounts Receivable: 59128000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 59128000.00
HCAT balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -53326000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -53326000.00
HCAT balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -3700000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -3700000.00
HCAT cash_flow (annual, 2025-12-31) — Amortization Of Securities: -1565000.00
HCAT cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -287000.00
HCAT cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 117123000.00
HCAT cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 81454000.00
HCAT income_statement (annual, 2025-12-31) — Basic Average Shares: 69896000.00
HCAT income_statement (quarterly, 2025-12-31) — Basic Average Shares: 70998000.00
HCAT income_statement (annual, 2025-12-31) — Basic EPS: -2.55
HCAT income_statement (quarterly, 2025-12-31) — Basic EPS: -1.28
HCAT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 249645000.00
HCAT cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 40305000.00
HCAT cash_flow (annual, 2025-12-31) — Capital Expenditure: -21553000.00
HCAT cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -5596000.00
HCAT cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -19780000.00
HCAT cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -5142000.00
HCAT balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 17987000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 17987000.00
HCAT balance_sheet (annual, 2025-12-31) — Capital Stock: 1608840000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1608840000.00
HCAT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 50814000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 50814000.00
HCAT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 95732000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 95732000.00
HCAT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -235782000.00
HCAT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -434000.00
HCAT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 36193000.00
HCAT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 1009000.00
HCAT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 731000.00
HCAT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 9912000.00
HCAT cash_flow (annual, 2025-12-31) — Change In Account Payable: -11512000.00
HCAT cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 4217000.00
HCAT cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -3967000.00
HCAT cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -1061000.00
HCAT cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 607000.00
HCAT cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -2697000.00
HCAT cash_flow (annual, 2025-12-31) — Change In Payable: -11512000.00
HCAT cash_flow (quarterly, 2025-12-31) — Change In Payable: 4217000.00
HCAT cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -11512000.00
HCAT cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 4217000.00
HCAT cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 1569000.00
HCAT cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -365000.00
HCAT cash_flow (annual, 2025-12-31) — Change In Receivables: -1809000.00
HCAT cash_flow (quarterly, 2025-12-31) — Change In Receivables: 900000.00
HCAT cash_flow (annual, 2025-12-31) — Change In Working Capital: -15112000.00
HCAT cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 994000.00
HCAT cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -1809000.00
HCAT cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 900000.00
HCAT cash_flow (annual, 2025-12-31) — Changes In Cash: -198858000.00
HCAT cash_flow (quarterly, 2025-12-31) — Changes In Cash: 10487000.00
HCAT balance_sheet (annual, 2025-12-31) — Common Stock: 1608840000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Common Stock: 1608840000.00
HCAT balance_sheet (annual, 2025-12-31) — Common Stock Equity: 245780000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 245780000.00
HCAT cash_flow (annual, 2025-12-31) — Common Stock Payments: -5000000.00
HCAT cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
HCAT income_statement (annual, 2025-12-31) — Cost Of Revenue: 159461000.00
HCAT income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 35296000.00
HCAT balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 13494000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 13494000.00
HCAT balance_sheet (annual, 2025-12-31) — Current Assets: 169307000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Current Assets: 169307000.00
HCAT balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 3779000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 3779000.00
HCAT balance_sheet (annual, 2025-12-31) — Current Debt: 1627000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Current Debt: 1627000.00
HCAT balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 5406000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 5406000.00
HCAT balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 56107000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 56107000.00
HCAT balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 56107000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 56107000.00